Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 3상모집 예정· COVID-19 Vaccines소아 및 성인에서의 COVID-19 백신 연구
A Study of COVID-19 Vaccine(s) in Children and Adults
리드: 바이오엔테크 · 협력: 화이자
- 1상모집 중· HIV -1 InfectionHIV 감염 여부와 관계없는 성인에서 RNA 기반 백신 BNT168의 안전성 및 면역 반응 평가 임상시험
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
리드: 바이오엔테크
- 4상모집 중· COVID-19 Vaccines18-64세 건강한 성인에서 COVID-19 백신에 대한 연구
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
리드: 바이오엔테크 · 협력: 화이자
- 3상모집 중· Metastatic Castration-resistant Prostate CancerA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
리드: 바이오엔테크
- 1/2상모집 중· Advanced Solid Tumor CancerEarly-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
리드: 바이오엔테크
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-small Cell Lung Cancer (NSCLC)A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
리드: BMS · 협력: 바이오엔테크
- 2/3상모집 중· Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-Small Cell Lung Cancer (NSCLC)A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
리드: BMS · 협력: 바이오엔테크
- 2상모집 중· Recurrent GlioblastomaA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
리드: 바이오엔테크 · 협력: BMS
- 2/3상모집 중· Untreated, Unresectable, or Metastatic Colorectal CancerA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
리드: BMS · 협력: 바이오엔테크
- 3상모집 중단 (진행 중)· COVID-19A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
리드: 바이오엔테크 · 협력: 화이자
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (PDAC)A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
리드: 바이오엔테크 · 협력: BMS
- 3상모집 중· Breast NeoplasmsROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중· CRC (Colorectal Cancer)PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
협력: 바이오엔테크
- 2상모집 중· Solid TumorsDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중· Locally Advanced Breast CancerA Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
리드: 바이오엔테크
- 3상모집 중· Extensive-stage Small-cell Lung CancerSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
리드: 바이오엔테크 · 협력: BMS
- 1/2상모집 중· Advanced Solid TumorSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
리드: 바이오엔테크
- 2/3상모집 중· Non-small Cell Lung CancerSafety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중단 (진행 중)· Muscle-invasive Urothelial CarcinomaA Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
리드: 로슈 · 협력: 바이오엔테크
- 1/2상모집 예정· HCCA Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Locally Advanced Breast CancerSafety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중단 (진행 중)· Extensive-stage Small-cell Lung CancerSafety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
리드: 바이오엔테크
- 3상모집 중단 (진행 중)· Triple Negative Breast Cancer(TNBC)PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
협력: 바이오엔테크
- 3상모집 중단 (진행 중)· HER2-positive Breast CancerA Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
협력: 바이오엔테크
- 3상모집 중단 (진행 중)· Metastatic Breast CancerA Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
협력: 바이오엔테크
- 1상모집 중단 (진행 중)· Advanced Malignant Solid TumorSafety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors
리드: 바이오엔테크
- 1상모집 중단 (진행 중)· Malignant Solid TumorA Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Adenocarcinoma, Pancreatic DuctalA Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
리드: 로슈 · 협력: 바이오엔테크
- 1/2상모집 중· Advanced Solid TumorsA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· TuberculosisSafety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
리드: 바이오엔테크
- 3상모집 중단 (진행 중)· Non Small Cell Lung CancerONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· NSCLCA Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· SCLCA Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Neuroendocrine NeoplasmA Study of PM8002 in Combination With Chemotherapy in Patients With NEN
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Advanced Non-Small Cell Lung CancerA Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
리드: 리제네론 · 협력: 바이오엔테크
- 1상모집 중단 (진행 중)· Non Small Cell Lung CancerA Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
협력: 바이오엔테크
- 3상완료· SARS-CoV-2 VirusA Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
리드: 바이오엔테크 · 협력: 화이자
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorFirst-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· TNBCA Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· SCLCA Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
협력: 바이오엔테크
- 1/2상모집 중· HER2-positive Advanced Solid TumorA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1상모집 중· Lymphocytic LeukemiaA Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
협력: 바이오엔테크, 머크(MSD)
- 1/2상모집 중· Malignant NeoplasmPM8002 in the Treatment of Patients With Advanced Solid Tumors
협력: 바이오엔테크
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.